A structure-based drug discovery platform screening over 10 billion compounds to identify first-in-class oral or topical small-molecule inhibitors of the IL4 receptor, offering an alternative to injectable antibody thera...
Computational platform combining flexible docking with AI/ML models to predict activators and inhibitors of the SGLT1 and GLUT5 transporters. Uses structural data and activity databases to screen dietary ingredients and ...